Press Releases

Health News Posted on Tuesday, April 30, 2024

Premium Press Releases »

EnGeneIC and Singapore Institute of Advanced Medicine Holdings Forge Strategic Partnership to Revolutionise Cancer Treatment in Asia

SYDNEY, Australia, June 06, 2024 (GLOBE NEWSWIRE) -- EnGeneIC, a clinical-stage biopharmaceutical company pioneering the development of a First-in-Class targeted nanocell for cancer therapy has today announced strategic partnerships with ...

Read More

Get Ready for Winter with the Latest Issue of Build & Renovate Magazine

AUCKLAND, New Zealand, June 06, 2024 (GLOBE NEWSWIRE) -- The shortest day of the year is fast approaching, and as we crank up our heaters, Build & Renovate Magazine's latest edition is here to help you stay warm and cosy this winter. ...

Read More

Mediktor Acquires Sensely and Consolidates Its Position as a Leader in AI Healthcare Solutions

BARCELONA, Spain and SAN FRANCISCO, June 05, 2024 (GLOBE NEWSWIRE) -- Mediktor , the leading digital healthcare company, has announced the acquisition of Sensely , a San Francisco-based, digital healthcare provider that pioneered an ...

Read More

Deep Integration of Proven AI Tools Into Philips Cardiovascular Ultrasound Systems to Better Diagnose More Cardiac Disease Patients

June 4, 2024 New FDA-cleared AI-enabled applications include the industry’s first automated tool for segmental wall motion scoring of the heart to quickly and objectively identify disorders including coronary artery disease and cardio-oncology ...

Read More

Press Releases »

NHS England Reimburses Optilume® Urethral Drug Coated Balloon as Part of the Specialised Services Device Programme

PORTSMOUTH, N.H. , April 30, 2024 /PRNewswire/ -- Laborie Medical Technologies Corp. (Laborie), a leading diagnostic and therapeutic medical technology company, welcomed the inclusion of Optilume ® Urethral Drug-Coated Balloon (DCB) into ...

Read More

Foresee Pharmaceuticals Announces First Subject Dosed in its First-in-Human Clinical Trial of FP-020

TAIPEI , April 30, 2024 /PRNewswire/ -- Foresee Pharmaceuticals (TPEx: 6576), ("Foresee") today announced that the first subject has been dosed in its Phase 1 clinical trial of FP-020 in Australia . The Phase 1 clinical trial is a ...

Read More

ReNew Health to Pay $7 Million to Settle First-of-its-Kind COVID-19 False Claims Act Case

Zimmerman Reed announces $7 million settlement for the U.S. and State of California in a first-of-its kind False Claims Act case involving a COVID-19 waiver program. MINNEAPOLIS, Minn. , April 29, 2024 /PRNewswire-PRWeb/ -- ...

Read More

UT Health San Antonio-led STRONG STAR Consortium secures $17 million in DOD research funding for brain injuries, PTSD and more

A national consortium based at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) was awarded $17 million by the U.S. Department of Defense for new research in traumatic brain injury and psychological ...

Read More
More Press Releases

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.